Oracle CEO Mike Sicilia said the collaboration could help accelerate research, connect more patients to clinical trials and ...

Oracle announced that it has signed a non-binding agreement with AstraZeneca to test the potential for AI and real world ...

While analysts expect Microsoft's earnings to grow about 15% annually in the coming years, Oracle is expected to deliver 23% ...

The AstraZeneca collaboration is a credible wedge into recurring, software-like healthcare AI (Cerner upgrades + trial ...

AstraZeneca has partnered with Oracle to use AI and real-world health data in clinical trials. The deal was announced on October 20, 2026. It aims to find eligi ...

A Michigan couple has filed a lawsuit against a California cheese company after their 18-month-old daughter developed kidney ...

Oracle today announced an agreement with AstraZeneca to explore how AI and real-world data can help clinicians identify ...

Oct 20 () - AstraZeneca said on Tuesday that it is working with Oracle to ‌use AI and real-world data to identify ‌eligible patients for clinical trials and monitor safety signals, among ​other ...

Against the backdrop of the rapidly advancing AI era, this academic paper challenges the common assumption that ancient myths ...

Debt-funded AI cloud providers are back under pressure as concerns about borrowing costs spread across the group. First of ...

BNP Paribas survey shows Oracle’s GenAI-driven inflection as cloud spending rebounds in Europe; AWS leads while Adobe/Zoom ...

AstraZeneca and Oracle will use AI and real-world health data to find trial patients sooner, starting with a hypertension ...